Active Awards Portfolio Dashboard
It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards
Disease | Cell Type | Therapeutic or Technology | Institution | Stage | Project Objective | Details |
---|---|---|---|---|---|---|
Leukemia, Acute Myeloid (AML) | Cancer Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
IND | |
Neurological Disorders | Adult Stem Cell | Gene-modified, personalized cell therapy | UC Davis |
![]() |
IND | |
B cell cancers, Solid Tumors |
Cancer Stem Cell | Biologic | Nammi Therapeutics, Inc. |
![]() |
IND | |
B cell cancers | Somatic Cell | Gene-modified, donor cell therapy | Angiocrine |
![]() |
Clinical Trial, Phase 3 | |
Immune Disease | Adult Stem Cell | Donor cell therapy | Ossium Health |
![]() |
IND | |
Parkinson's Disease | iPS Cell | Donor cell therapy | Ryne Bio |
![]() |
IND | |
Bone or Cartilage Disease, Hearing Loss, Intellectual Disability, Metabolic Disorders, Vision Loss |
Somatic Cell | Personalized cell therapy | Immusoft Corporation |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Spinal Cord Injury |
Embryonic Stem Cell, iPS Cell |
Gene-modified, personalized cell therapy | BrainXell Therapeutics |
![]() |
Development Candidate, Proof of Concept | |
Heart failure | iPS Cell | Gene Therapy, cell free | UC Berkeley |
![]() |
Development Candidate, Proof of Concept | |
Neurological Disorders, Sanfilippo Syndrome/MPS III |
Embryonic Stem Cell | Gene-modified, donor cell therapy | Lundquist Institute |
![]() |
Development Candidate, Proof of Concept | |
Intervertebral disc degeneration | iPS Cell | Donor cell therapy | Cedars-Sinai |
![]() |
Proof of Concept | |
Tendon/Ligament/Connective Tissue Injury or Disorder | Embryonic Stem Cell | Biologic | Scripps Health |
![]() |
Development Candidate, Proof of Concept | |
Brain Cancer | Cancer Stem Cell | Small molecule therapy | UCLA |
![]() |
Development Candidate | |
Autism, Intellectual Disability, Metabolic Disorders |
iPS Cell | Gene Therapy, cell free | UCLA |
![]() |
Development Candidate, Proof of Concept | |
Lung Disease, Fibrosis | Adult Stem Cell | Small molecule therapy | Rubedo Life Sciences Inc. |
![]() |
Development Candidate, Proof of Concept | |
Duchenne Muscular Dystrophy |
Other, Somatic Cell |
Gene Therapy, cell free | UC Davis |
![]() |
Proof of Concept | |
UC Berkeley | ||||||
Greenstone Biosciences | ||||||
Breast Cancer | Adult Stem Cell | Small molecule therapy | UCLA |
![]() |
Development Candidate, Proof of Concept | |
UCLA | ||||||
Spinal Cord Injury |
Embryonic Stem Cell, iPS Cell |
Donor cell therapy | Gladstone |
![]() |
Development Candidate, Proof of Concept | |
COH | ||||||
Metabolic Disorders | Adult Stem Cell | Gene-modified, personalized cell therapy | Rampart Bioscience |
![]() |
IND | |
Osteoarthritis | Somatic Cell | Gene Therapy, cell free | Genascence Corporation |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 |
Pages
- « first
- ‹ previous
- 1
- 2
- 3
- 4